Page 35 - Genomic Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A new COVID test promises to do what no other diagnostic tool has been capable of doing yet—diagnosing COVID in patients in just five minutes.

The development, hailed as a world first, could be the breakthrough to help get crowds back to sporting events and festivals across the UK this summer.

 E-Mail The Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai and Rumi Scientific announced today that they will team up to initiate a drug discovery pipeline for rare genetic disorders that carry a high risk of autism. The project will initially involve the development and use of a platform that mimics the development of brain tissues, at high speed, allowing researchers to gain insights into how cells respond to three known genes implicated in autism. "Over the past several years, more than 100 genes have been identified that confer very high ri...

Study discovers new measures to predict risk of bowel diseases ANI | Updated: Dec 27, 2020 23:01 IST Washington [US], December 27 (ANI): Mount Sinai researchers claim to have discovered new measures to predict risk for inflammatory bowel diseases (IBD) including Crohn's disease and ulcerative colitis. The study published in the research journal Gastroenterology shows that the polygenic risk scores, built using association data from multiple populations in Mount Sinai's multi-ethnic BioMe Biobank, maximized IBD predictions for every population in the bioba...

Using genetic data from nearly 30,000 people, Mount Sinai researchers have built risk scores from a combination of datasets representing distinct ancestral popu